Skip to main content
Erschienen in: European Journal of Epidemiology 1/2014

01.01.2014 | NEUROEPIDEMIOLOGY

Irritable bowel syndrome correlates with increased risk of Parkinson’s disease in Taiwan

verfasst von: Shih-Wei Lai, Kuan-Fu Liao, Cheng-Li Lin, Fung-Chang Sung

Erschienen in: European Journal of Epidemiology | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

This study investigated whether an association exists between irritable bowel syndrome (IBS) and the risk of Parkinson’s disease. This is a retrospective cohort study using the dataset of the Taiwan National Health Insurance Program from 2000 to 2010. We identified 23,875 patients (aged 20 years or older) with newly diagnosed IBS as the IBS group and 95,500 subjects without IBS as the non-IBS group for comparison. The main outcome was incident Parkinson’s disease compared between both groups by the end of 2010. We measured the hazard ratio (HR) to evaluate the association between IBS and Parkinson’s disease. The overall incidence of Parkinson’s disease in the IBS group was 1.76-fold higher than that in the non-IBS group (16.4 vs. 9.33 per 10,000 person-years). The multivariable Cox proportional hazards regression analysis revealed that the adjusted HR of Parkinson’s disease associated with IBS was 1.48 (95 % CI 1.27, 1.72), compared with the non-IBS group. Age, women, hypertension, dementia, cerebrovascular disease and depression were also significantly associated with Parkinson’s disease. Patients with irritable bowel syndrome are at an increased risk of developing Parkinson’s disease. Further studies are required to explore the pathophysiological connection between these disorders.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(712–721):e714. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(712–721):e714.
3.
Zurück zum Zitat Jellema P, van der Windt DA, Schellevis FG, van der Horst HE. Systematic review: accuracy of symptom-based criteria for diagnosis of irritable bowel syndrome in primary care. Aliment Pharmacol Ther. 2009;30:695–706.PubMedCrossRef Jellema P, van der Windt DA, Schellevis FG, van der Horst HE. Systematic review: accuracy of symptom-based criteria for diagnosis of irritable bowel syndrome in primary care. Aliment Pharmacol Ther. 2009;30:695–706.PubMedCrossRef
4.
Zurück zum Zitat Mach T. The brain-gut axis in irritable bowel syndrome–clinical aspects. Med Sci Monit. 2004;10:RA125–31.PubMed Mach T. The brain-gut axis in irritable bowel syndrome–clinical aspects. Med Sci Monit. 2004;10:RA125–31.PubMed
5.
Zurück zum Zitat Ohman L, Simren M. New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. Dig Liver Dis. 2007;39:201–15.PubMedCrossRef Ohman L, Simren M. New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. Dig Liver Dis. 2007;39:201–15.PubMedCrossRef
6.
Zurück zum Zitat Katiraei P, Bultron G. Need for a comprehensive medical approach to the neuro-immuno-gastroenterology of irritable bowel syndrome. World J Gastroenterol. 2011;17:2791–800.PubMed Katiraei P, Bultron G. Need for a comprehensive medical approach to the neuro-immuno-gastroenterology of irritable bowel syndrome. World J Gastroenterol. 2011;17:2791–800.PubMed
7.
Zurück zum Zitat Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol. 2006;5:235–45.PubMedCrossRef Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol. 2006;5:235–45.PubMedCrossRef
8.
Zurück zum Zitat Poewe W. Non-motor symptoms in Parkinson’s disease. Eur J Neurol. 2008;15(Suppl 1):14–20.PubMedCrossRef Poewe W. Non-motor symptoms in Parkinson’s disease. Eur J Neurol. 2008;15(Suppl 1):14–20.PubMedCrossRef
9.
Zurück zum Zitat Chaudhuri KR, Martinez-Martin P, Schapira AHV, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord. 2006;21:916–23.PubMedCrossRef Chaudhuri KR, Martinez-Martin P, Schapira AHV, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord. 2006;21:916–23.PubMedCrossRef
10.
Zurück zum Zitat Martinez-Martin P, Schapira AHV, Stocchi F, et al. Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients. Mov Disord. 2007;22:1623–9.PubMedCrossRef Martinez-Martin P, Schapira AHV, Stocchi F, et al. Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients. Mov Disord. 2007;22:1623–9.PubMedCrossRef
11.
Zurück zum Zitat Natale G, Pasquali L, Paparelli A, Fornai F. Parallel manifestations of neuropathologies in the enteric and central nervous systems. Neurogastroenterol Motil. 2011;23:1056–65.PubMedCrossRef Natale G, Pasquali L, Paparelli A, Fornai F. Parallel manifestations of neuropathologies in the enteric and central nervous systems. Neurogastroenterol Motil. 2011;23:1056–65.PubMedCrossRef
12.
Zurück zum Zitat Cersosimo MG, Benarroch EE. Pathological correlates of gastrointestinal dysfunction in Parkinson’s disease. Neurobiol Dis. 2012;46:559–64.PubMedCrossRef Cersosimo MG, Benarroch EE. Pathological correlates of gastrointestinal dysfunction in Parkinson’s disease. Neurobiol Dis. 2012;46:559–64.PubMedCrossRef
13.
Zurück zum Zitat Ferrer I, Lopez-Gonzalez I, Carmona M, et al. Neurochemistry and the non-motor aspects of PD. Neurobiol Dis. 2012;46:508–26.PubMedCrossRef Ferrer I, Lopez-Gonzalez I, Carmona M, et al. Neurochemistry and the non-motor aspects of PD. Neurobiol Dis. 2012;46:508–26.PubMedCrossRef
14.
Zurück zum Zitat Lai SW, Liao KF, Liao CC, et al. Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine. 2010;89:295–9.PubMedCrossRef Lai SW, Liao KF, Liao CC, et al. Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine. 2010;89:295–9.PubMedCrossRef
15.
Zurück zum Zitat Lai SW, Su LT, Lin CH, et al. Polypharmacy increases the risk of Parkinson’s disease in older people in Taiwan: a population-based study. Psychogeriatrics. 2011;11:150–6.PubMedCrossRef Lai SW, Su LT, Lin CH, et al. Polypharmacy increases the risk of Parkinson’s disease in older people in Taiwan: a population-based study. Psychogeriatrics. 2011;11:150–6.PubMedCrossRef
16.
Zurück zum Zitat Lai SW, Chen PC, Liao KF, et al. Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study. Am J Gastroenterol. 2012;107:46–52.PubMedCrossRef Lai SW, Chen PC, Liao KF, et al. Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study. Am J Gastroenterol. 2012;107:46–52.PubMedCrossRef
17.
Zurück zum Zitat Peters TJ. Multifarious terminology: multivariable or multivariate? Univariable or univariate? Paediatr Perinat Epidemiol. 2008;22:506.PubMedCrossRef Peters TJ. Multifarious terminology: multivariable or multivariate? Univariable or univariate? Paediatr Perinat Epidemiol. 2008;22:506.PubMedCrossRef
18.
Zurück zum Zitat Lebouvier T, Neunlist M, Bruley des Varannes S, et al. Colonic biopsies to assess the neuropathology of Parkinson’s disease, its relationship with symptoms. PLoS One. 2010;5:e12728.PubMedCentralPubMedCrossRef Lebouvier T, Neunlist M, Bruley des Varannes S, et al. Colonic biopsies to assess the neuropathology of Parkinson’s disease, its relationship with symptoms. PLoS One. 2010;5:e12728.PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Pouclet H, Lebouvier T, Coron E, et al. A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson’s disease. Neurobiol Dis. 2012;45:305–9.PubMedCrossRef Pouclet H, Lebouvier T, Coron E, et al. A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson’s disease. Neurobiol Dis. 2012;45:305–9.PubMedCrossRef
20.
Zurück zum Zitat Cersosimo MG, Benarroch EE. Autonomic involvement in Parkinson’s disease: pathology, pathophysiology, clinical features and possible peripheral biomarkers. J Neurol Sci. 2012;313:57–63.PubMedCrossRef Cersosimo MG, Benarroch EE. Autonomic involvement in Parkinson’s disease: pathology, pathophysiology, clinical features and possible peripheral biomarkers. J Neurol Sci. 2012;313:57–63.PubMedCrossRef
21.
Zurück zum Zitat Chao CH, Lin CL, Wang HY, et al. Increased subsequent risk of erectile dysfunction in patients with irritable bowel syndrome: a nationwide population-based cohort study. Andrology. 2013;1:793–8.PubMedCrossRef Chao CH, Lin CL, Wang HY, et al. Increased subsequent risk of erectile dysfunction in patients with irritable bowel syndrome: a nationwide population-based cohort study. Andrology. 2013;1:793–8.PubMedCrossRef
Metadaten
Titel
Irritable bowel syndrome correlates with increased risk of Parkinson’s disease in Taiwan
verfasst von
Shih-Wei Lai
Kuan-Fu Liao
Cheng-Li Lin
Fung-Chang Sung
Publikationsdatum
01.01.2014
Verlag
Springer Netherlands
Erschienen in
European Journal of Epidemiology / Ausgabe 1/2014
Print ISSN: 0393-2990
Elektronische ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-014-9878-3

Weitere Artikel der Ausgabe 1/2014

European Journal of Epidemiology 1/2014 Zur Ausgabe